Serum microRNAs are non-invasive biomarkers for the presence and progression of subarachnoid haemorrhage.

miRNAs are important regulators of translation and have been associated with the pathogenesis of a number of cardiovascular diseases including stroke and may be possible prognostic biomarkers. The purpose of the present study was to determine the expression levels of miRNAs in the sera of subarachnoid haemorrhage (SAH) patients and to evaluate their relationships with the severity and clinical outcome of SAH. Serum samples on day 3 after the onset of SAH were subjected to microarray analysis with Exqion miRCURY LNA array and quantitative PCR analysis. Serum samples from SAH patients (=60) and healthy controls (=10) were subjected to quantitative PCR analysis. The severities and clinical outcomes of the SAH patients were evaluated with the WFNS grade and the Modified Rankin Scale (mRS). Three miRNAs, , and were significantly up-regulated in the sera of SAH patients when compared with the healthy controls. The serum and levels were significantly higher in the patients with severe SAH and a poor outcome than in those with mild SAH and a good outcome (<0.05). The areas under the receiver operating characteristic (ROC) curves (AUCs) of , and to distinguish the SAH patients from the healthy controls were 0.958 (<0.001), 0.950 (<0.001) and 0.843 (<0.001) respectively. Taken together, these results indicate that and are potentially valuable indicators of the diagnosis, severity and prognosis of SAH, and was a potentially valuable indicator of the diagnosis of SAH.